Navigation Links
uniQure Appoints Hans Christian Rohde Chief Commercial Officer
Date:12/6/2012

AMSTERDAM, The Netherlands, December 6, 2012 /PRNewswire/ --

uniQure B.V., a leader in the field of human gene therapy, today announced the appointment of Hans Christian Rohde as Chief Commercial Officer.

Mr. Rohde joins uniQure from Basilea Pharmaceutica (SIX: BSLN) where from 2007 he was Chief Commercial Officer and member of the company's executive management committee with responsibility for global commercial operations, marketing, supply chain, medical affairs, pricing and market access.

"We are very pleased with Hans Christian's appointment," says Jörn Aldag, CEO of uniQure.  "With the approval of Glybera we need to rapidly build and expand our commercial organization to enable the successful roll-out of Glybera and provide access to this crucial treatment to as many patients as possible. Hans Christian's experience and successful track-record in major biotechnology companies such as Basilea, Merck-Serono and Biogen Idec provide us with the necessary leadership qualities to successfully commercialize Glybera."

Hans Christian Rohde (M.Sc., MBA) has almost 25 years experience in commercial roles at leading biotechnology and pharmaceutical companies. Prior to Basilea Pharmaceutica, Mr. Rohde was Corporate Vice President, Head of Global Therapeutic Areas Reproductive Health and Endocrinology at Merck-Serono from 2003 until 2007. Before this he was responsible for international marketing and global market development at Biogen Idec. From 1992 until 2000, Mr Rohde held positions of increasing commercial responsibility at Novo Nordisk. Mr. Rohde started his career at Laboratoires Syntex.

About uniQure

uniQure is a world leader in the development of human gene based therapies. uniQure's Glybera, a gene therapy for the treatment of lipoprotein lipase deficiency has been approved in the European Union, and is the first approved gene therapy in the Western world. uniQur
'/>"/>

SOURCE uniQure B.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. uniQure Licenses RNA Interference Technology to Advance Huntingtons Disease Program
2. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
3. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
4. Nephros Appoints John C. Houghton as President and Chief Executive Officer
5. Elsevier Appoints New President of Elsevier CPM Resource Center
6. GenWay Biotech Appoints New Vice President of Custom/OEM
7. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
8. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Hill-Rom Appoints Alton Shader President of Hill-Rom North America
11. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... DUBLIN , May 06, 2015 Research ... announced the addition of the "Cannulas Market ... Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) ... Global Forecast to 2020" report to their ... expected to grow at a CAGR of 5.6% ...
(Date:5/6/2015)... May 6, 2015  Membership in Medicare Supplement plans ... Healthcare Business Strategy report released by Mark Farrah ... Medigap or Med Supp plans, covered approximately 11.2 ... 5.2% increase from 2013. Between 2013 and 2014, ... covered lives.  Though UnitedHealth was the segment growth ...
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... "Energy based Ablation Devices - Global Strategic Business Report" ... comprehensive analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual ... 2020. Also, a seven-year historic analysis is provided for these ...
Breaking Medicine Technology:Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... Oct. 12 Cannabis Science, Inc. (OTC Bulletin Board: ... developing pharmaceutical cannabis products, is pleased to announce guidance ... Applications for its cannabis clinical trials. The Company is ... current shareholders for a new class of common shares ...
... 12 OXIS International, Inc., (OTC Bulletin Board: ... Cataldo, Chief Executive Officer, and Bernie Landes, President, will ... of the fastest growing investor and stock trading communities ... will be held on Tuesday, October 12, 2010, at ...
Cached Medicine Technology:Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock 2Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock 3Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock 4Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock 5Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock 6Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock 7OXIS International Executives Interviewed on StockGoodies.com Radio 2
(Date:5/6/2015)... (PRWEB) May 06, 2015 As ... the HIMSS EMR Adoption Model, the hospital looked ... patient engagement and automate processes. The leadership team ... paper-driven to electronic workflows, patient registration still required ... of consents. With HIMSS Stage 7 attestation fast ...
(Date:5/6/2015)... May 06, 2015 Experienced Vancouver air ... recently announced that they will now conduct their cooling ... complexes in addition to commercial and residential units. Strata ... require a lot of technical knowledge as well as ... an installation we will take away any old air ...
(Date:5/6/2015)... 06, 2015 Prime Pacific Health ... excited to announce a new series of universal, ... industry’s carbon footprint while improving treatment efficacy and ... Eco-Flex™, the world’s first waste hose designed ... for hydrotherapists,” claims the company’s president, Mr. Delmar ...
(Date:5/6/2015)... 06, 2015 Animals make just as good ... also good for your health. An Ohio veterinarian ... increase he's seeing with health advantages of owning a pet. ... it comes to pet ownership, there are proven health benefits ... Scott Leffler of the Animal Medical Center of ...
(Date:5/6/2015)... 06, 2015 Inversion Studios, a ... yoga and Pilates classes, provides personalized individual instruction ... starting with its new Pilates Ring magic circle. ... becoming leaner, stronger, more centered and graceful, Inversion ... fresh venue to healthy fitness through yoga and ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3
... Care Payments, WASHINGTON, Sept. 12 Home ... and 11 for "March on Washington,and Lobby Days" ... home health payments. Participants met with their respective,members ... meeting with,representatives from 45 states., Agency members ...
... with heart disease at risk by affecting blood vessels and ... of Edinburgh and Ume University measured the effects of diesel ... have previously experienced a heart attack. , The research, ... New England Journal of Medicine, found that inhalation of diesel ...
... Idraparinux effective, but research found higher rates of bleeding ... -- Three studies on the new anti-clotting medication idraparinux ... thrombosis (DVT) and for the long-term prevention of blood ... usual treatment for potentially life-threatening pulmonary embolisms. , And, ...
... N.J., Sept. 12 Leaders of the,medical community ... association to address increasing concerns that the quality ... of the practice of medicine, are,in jeopardy. ... was,created to provide a strong, unified voice for ...
... GSI Securitization,Inc. (Pink Sheets: GSIEF) Gunther ... engaged in a,project with nine separate hospitals and ... for healthcare accounts receivable. This is part of,the ... of receivables in the,$2-trillion+ healthcare market. The names ...
... ANTONIO, Sept. 12 The National Alliance,for Hispanic ... program,called Hypertension...Control is in your Hands (Presion alta...El ... raising awareness of hypertension (high,blood pressure), promoting prevention, ... under control. The Alliance is conducting,education and blood ...
Cached Medicine News:Health News:National Association for Home Care & Hospice (NAHC) Members Take Their Case to Capitol Hill 2Health News:Diesel exhaust may increase risk in patients with heart disease 2Health News:New Drug No Substitute for Standard Blood-Clot Therapy 2Health News:New Drug No Substitute for Standard Blood-Clot Therapy 3Health News:New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare 2Health News:Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio 2Health News:Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio 3
... surgical navigation for Spine ... to integrate C-arm fluoroscopy ... Instratrak 3500 - spine ... system for ENT, cranial ...
... removes the constraints that previously limited the ... expandable to as many slices as CT ... integrated circuit (ASIC) chip, is responsible for ... premium configuration of the Mx8000 family of ...
... IDT 16 is Philips premium 16-slice CT scanner. ... performed to automatically delivering high quality, advanced results, ... in a platform that has been the most ... do comprehensive organ assessment literally within seconds, and ...
... Boldly setting the standard for everyday, ... improves temporal and spatial image resolution ... thinner slice, 3D volume imaging., An ... versatile detector array complement this supercharged ...
Medicine Products: